Pharmaceutical company Reig Jofre, a CataloniaBio member, is awaiting approval from international healthcare authorities for 100 new drug listings the company is developing over the coming three years. This news was announced by Reig Jofre CEO Ignasi Biosca in Madrid, in his presentation of the company’s results.

Photo: Ignasi Biosca, Reig Jofre CEO and president of CataloniaBio © Ara.cat